Position in NAGE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,198,391
-$2,780,287 QoQ
Shares Held
1,405,531
-0.4% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NAGE ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in NAGE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,198,391 | 1,405,531 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,978,678 | 1,411,742 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,159,584 | 1,196,097 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,234,302 | 85,656 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $380,437 | 55,136 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $236,151 | 44,473 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $214,944 | 58,889 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $381,506 | 139,746 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $69,679 | 20,023 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,077 | 1,453 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,546 | 1,059 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $10,244 | 6,526 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,950 | 17,615 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,247 | 17,409 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $29,407 | 23,909 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $40,789 | 24,425 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $53,320 | 21,675 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $205,732 | 55,009 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $329,927 | 52,620 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $980,290 | 99,421 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $474,508 | 50,804 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $731,011 | 152,294 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $603,906 | 150,600 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $926,633 | 201,881 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $718,565 | 220,419 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||